The need to look beyond the function’s traditional performance measures to the one that really matters-patient outcomes.
Filip Surmont, MD
Advertisement
Articles by Filip Surmont, MD
A description of the changing role of the medical affairs function in pharmaceutical companies and the subsequent evolution to a never ending measurement of the output of medical affairs. How to overcome this quest for sometimes meaningless numbers to justify its existence.
Advertisement
Latest Updated Articles
Medical Affairs’ Search for MeaningPublished: April 25th 2018 | Updated:
- Medical Affairs’ Search for Meaning
Published: October 1st 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer’s Proven Playbook: Buy, Partner, Scale, Spin-Off, Optimize
2
Bristol Myers Squibb Expands its Strategic Collaboration with Sarah Cannon Research Institute
3
HHS and FDA Appoint Richard Pazdur as Director of The Center for Drug Evaluation and Research
4
AstraZeneca Stock Becomes UK’s Biggest Stock
5
